C HRONIC REJECfION after transplantation, including experimental composite tissue grafts, is a major cause of late allograft dysfunction. Recently, we have shown that chronic rejection of rat hind limb transplants results in significant structural and immunological changes. 1 A cytokine which is known to exert a variety of immunoregulatory effects is transforming growth factor beta (TGFf3). This pleiotrophic factor has been shown to be expressed in normal skin.2 Most of its effects result in immunosuppression, but mitogenic effects are also described. Additionally, it has been implicated in causing hypertrophy of cardiac muscle as well as being involved in the onset of fibrosis. 3 The aim of this study was to investigate whether the expression of TGFf3 by infiltrating immunocytes is effected during chronic rejection after composite tissue transplantation and where TGFf3 mRNA expressing cells and the TGFf3 protein are localized.
MATERIALS AND METHODS
Chronic rejection after total hind limb transplantation (Lewis. RTII---> Brown Norway, RT'n; n = 5) was achieved by a limited course of immunosuppression (FK 506, 1 mg/kgld) for 100 days. Syngeneic animals (Lewis~ Lewis; n = 5) served as a control. Following 30 days of discontinuation of the immunosuppression. skin and muscle biopsies were taken. The local expression ofTGFf3 mRNA was investigated using in situ hybridization with S35 radiolabelled eDNA probes on 5 I-'m skin and muscle sections of syngeneic and chronically rejecting transplants snap-frozen on postoperative day 130. Immunohistochemistry was used for localization of the TG F f3 protein in those sections.
RESULTS
Upon in situ hyhridization, a strong upregulation of TGF{3 mRNA expressing cells was detected in sections of chronically rejecting allografts in both skin and muscle compared to the syngeneic controls. TGFf3-positive cells were localized to specific infiltrating immunocytes within the skin and especially the muscle. Corresponding to these findings. the TGF{3 protein was detected in the same areas. with a 0041-1315/97/$17.00 PII S0041-1345(96)00668-9 1542 stronger signal compared to the syngeneic controls. TGFf3 protein was found, furthermore, in the smooth muscle layer and endothelial cells of blood vessels. The muscle fibers showed no signal for TGFf3. Biopsies from the contralateral leg as well as from syngeneic animals showed no signal or only a weak signal.
CONCLUSION
TGFf3 expression is upregulated during chronic rejection after hind limb transplantation in both skin and muscle. Immunoregulation and fibrosis are two of a variety of effects that can be caused by this pleiotrophic protein.
These findings suggest a potential role for TGFf3 in the immune response during chronic rejection of composite tissue allografts, in which TGFf3 may counteract this process since most of the in vivo effects result in immunosuppression. Additionally, TGFf3 could induce fibrosis, and thus influence the structural and functional changes that are observed during the rejection process. The modulation of TGFf3 might be useful for the improvement of graft survival during chronic rejection.
